Generation Bio Return on Investment 2020-2023 | GBIO

Current and historical return on investment (ROI) values for Generation Bio (GBIO) over the last 10 years.
Generation Bio ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-12-31 $-0.14B inf%
2023-09-30 $-0.14B inf%
2023-06-30 $-0.14B inf%
2023-03-31 $-0.14B inf%
2022-12-31 $-0.14B inf%
2022-09-30 $-0.14B inf%
2022-06-30 $-0.14B inf%
2022-03-31 $-0.13B inf%
2021-12-31 $-0.12B inf%
2021-09-30 $-0.11B inf%
2021-06-30 $-0.10B inf%
2021-03-31 $-0.09B inf%
2020-12-31 $-0.08B inf%
2020-06-30 $-0.05B inf%
2020-03-31 $-0.05B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.193B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.482B 5.59
Dr Reddy's Laboratories (RDY) India $12.441B 19.67
Aspen Pharmacare (APNHY) South Africa $5.038B 0.00
BridgeBio Pharma (BBIO) United States $4.375B 0.00
Bausch Health Cos (BHC) Canada $3.183B 2.48
Amphastar Pharmaceuticals (AMPH) United States $2.009B 13.75
Supernus Pharmaceuticals (SUPN) United States $1.646B 0.00
Taysha Gene Therapies (TSHA) United States $0.447B 0.00
Assembly Biosciences (ASMB) United States $0.069B 0.00
Personalis (PSNL) United States $0.064B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00